Researchers may be in the early stages of discovering an effective strategy for inhibiting the virus that causes COVID-19, according to the results of a recent study.
The results of the findings from David A. Ostrov, Ph.D., of the University of Florida, were published in Pathogens in late November.
The report suggested that combining diphenhydramine — an antihistamine sold as Benadryl that is used for allergy symptoms — and lactoferrin — a protein found in cow and human milk — reduced replication of SARS-CoV-2 by 99% in lab tests on human lung and monkey cells.